Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,8693632,Alc27,Alcohol consumption QTL 27,2.2,0.791,drinking behavior trait (VT:0001422),calculated ethanol drink intake rate (CMO:0001615),6,34257766,53855198,Rat,n/a,region,qtl 1000,1578668,Bmd14,Bone mineral density QTL 14,3.8,,femur mineral mass (VT:0010011),total volumetric bone mineral density (CMO:0001728),6,6161722,76002731,Rat,n/a,region,qtl 1000,2301972,Bp325,Blood pressure QTL 325,4.8,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),6,1,75623393,Rat,n/a,region,qtl 1000,1578665,Bss16,Bone structure and strength QTL 16,4.4,,femur morphology trait (VT:0000559),bone trabecular cross-sectional area (CMO:0002311),6,6161722,76002731,Rat,n/a,region,qtl 1000,2293709,Bss23,Bone structure and strength QTL 23,5.18,0.0001,femur morphology trait (VT:0000559),femur cross-sectional area (CMO:0001661),6,1,43665660,Rat,n/a,region,qtl 1000,2293656,Bss28,Bone structure and strength QTL 28,6.79,0.0001,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),6,1,43665660,Rat,n/a,region,qtl 1000,2293650,Bss31,Bone structure and strength QTL 31,5.05,0.0001,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),6,1,43665660,Rat,n/a,region,qtl 1000,634318,Bw118,Body weight QTL 118,3.55,,abdominal fat pad mass (VT:1000711),abdominal fat pad weight (CMO:0000088),6,36260288,60606186,Rat,n/a,region,qtl 1000,634322,Bw12,Body weight QTL 12,0,,body mass (VT:0001259),body weight (CMO:0000012),7,10173862,55173862,Rat,n/a,region,qtl 1000,7411542,Bw127,Body weight QTL 127,5.5,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),6,1,42388212,Rat,n/a,region,qtl 1000,6893340,Cm77,Cardiac mass QTL 77,0.26,0.57,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),6,36260288,84763275,Rat,n/a,region,qtl 1000,1641898,Colcr4,Colorectal carcinoma resistance QTL4,3.71,0.0007,intestine integrity trait (VT:0010554),well differentiated malignant colorectal tumor surface area measurement (CMO:0002077),6,21515302,65784818,Rat,n/a,region,qtl 1000,2292589,Emca10,Estrogen-induced mammary cancer QTL 10,,0.048,mammary gland integrity trait (VT:0010552),post-insult time to mammary tumor formation (CMO:0000345),6,1120393,46120393,Rat,n/a,region,qtl 1000,1576309,Emca7,Estrogen-induced mammary cancer QTL 7,4,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),6,2537030,111715717,Rat,n/a,region,qtl 1000,7411603,Foco13,Food consumption QTL 13,5.5,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),6,1,42388212,Rat,n/a,region,qtl 1000,7411584,Foco4,Food consumption QTL 4,4.3,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),6,1,44015370,Rat,n/a,region,qtl 1000,9589129,Insul24,Insulin level QTL 24,19.06,0.001,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),6,1,42388212,Rat,n/a,region,qtl 1000,2293839,Kiddil2,Kidney dilation QTL 2,4.8,,kidney pelvis morphology trait (VT:0004194),hydronephrosis severity score (CMO:0001208),6,22042854,84763421,Rat,n/a,region,qtl 1000,2293841,Kiddil4,Kidney dilation QTL 4,4.4,,kidney pelvis morphology trait (VT:0004194),hydronephrosis severity score (CMO:0001208),6,22042854,84763421,Rat,n/a,region,qtl 1000,10401800,Kidm49,Kidney mass QTL 49,,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),6,16810107,61810107,Rat,n/a,region,qtl 1000,10401812,Kidm54,Kidney mass QTL 54,,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),6,16810107,61810107,Rat,n/a,region,qtl 1000,4145119,Mcs25,Mammary carcinoma susceptibility QTL 25,,0.0001,mammary gland integrity trait (VT:0010552),percentage of deaths in a study population during a period of time (CMO:0001024),6,7009971,115379601,Rat,n/a,region,qtl 1000,8552962,Pigfal16,Plasma insulin-like growth factor 1 level QTL 16,9.4,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),6,1,42388212,Rat,n/a,region,qtl 1000,8552910,Pigfal5,Plasma insulin-like growth factor 1 level QTL 5,4.3,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),6,19417887,64417887,Rat,n/a,region,qtl 1000,1300143,Rf14,Renal function QTL 14,2.92,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),6,34367436,80490628,Rat,n/a,region,qtl 1000,1300164,Rf15,Renal function QTL 15,3.12,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),6,13122958,57516539,Rat,n/a,region,qtl 1000,1331779,Rf38,Renal function QTL 38,2.876,,kidney blood vessel physiology trait (VT:0100012),absolute change in renal vascular resistance (CMO:0001900),6,34995656,75623393,Rat,n/a,region,qtl 1000,738024,Sach5,Saccharine consumption QTL 5,3.9,0.00039,consumption behavior trait (VT:0002069),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),6,1,44570292,Rat,n/a,region,qtl 1000,9589048,Scfw3,Subcutaneous fat weight QTL 3,4.57,0.001,subcutaneous adipose mass (VT:1000472),abdominal subcutaneous fat pad weight (CMO:0002069),6,1,42388212,Rat,n/a,region,qtl 1000,1354664,Slep2,Serum leptin concentration QTL 2,4.49,,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),6,1120393,75023446,Rat,n/a,region,qtl 1000,1331743,Uae28,Urinary albumin excretion QTL 28,4.5,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),6,1,41917988,Rat,n/a,region,qtl